• Symptomatic treatment of recurrent vertigo with/without cochlear signs
  • Symptomatic treatment of vestibular vertigo
  • Meniere Syndrome characterized by: vertigo, hearing loss or tinnitus

PO 8-16mg TDS

Tablet: 8mg

To be taken with food

Partial H1receptor agonist and H3 receptor antagonist. Non-sedative.

  • Nausea
  • Dyspepsia
  • Headaches
  • Hypersensitivity reactions
  • Hypersensitivity to components
  • Pheochromocytoma
  • MAOIs

                          Drug Status

Availability Prescription or OTC by Pharmacist
Pregnancy Unknown; Weigh risk vs benefit
Breastfeeding Unknown; Weigh risk vs benefit
Schedule Not controlled
BRAND NAME STRENGTH FORMULATION PACK SIZE MANUFACTURER DISTRIBUTOR
Besdiz 16mg Tablet 30’s Medisel Kenya Medisel Kenya
Besdiz 16mg Tablet 30’s Medisel Kenya Medisel Kenya
Be-Stedy 16mg Tablet 100’s Aurobindo Pharma Simba Pharma
Be-Stedy 24mg Tablet 100’s Aurobindo Pharma Simba Pharma
Betaserc 8mg Tablet 100’s Abbott Labs Harley’s Ltd
Betavert 16mg Tablet 100’s Sun Pharma Sun Pharma
Betavert 24mg Tablet 50’s Sun Pharma Sun Pharma
Vertease 16mg Tablet 30s Pharmevo Harley’s Ltd